Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 157 to 165 of 165 entries
Sorted by: Best Match Show Resources per page
Filters applied: Corrected and Republished Article
Republished: Quinidine hypersensitivity: a side effect of a forgotten antiarrhythmic.

Drug and therapeutics bulletin

El-Khatib L, Alrayes H, Sallam O, Elbanna A.
PMID: 33509835
Drug Ther Bull. 2021 May;59(5):77-79. doi: 10.1136/dtb.2021.235528rep. Epub 2021 Jan 28.

No abstract available.

Cite
El-Khatib L, Alrayes H, Sallam O, et al. Republished: Quinidine hypersensitivity: a side effect of a forgotten antiarrhythmic. Drug Ther Bull. 2021;59(5):77-79doi: 10.1136/dtb.2021.235528rep.
El-Khatib, L., Alrayes, H., Sallam, O., & Elbanna, A. (2021). Republished: Quinidine hypersensitivity: a side effect of a forgotten antiarrhythmic. Drug and therapeutics bulletin, 59(5), 77-79. https://doi.org/10.1136/dtb.2021.235528rep
El-Khatib, Layan, et al. "Republished: Quinidine hypersensitivity: a side effect of a forgotten antiarrhythmic." Drug and therapeutics bulletin vol. 59,5 (2021): 77-79. doi: https://doi.org/10.1136/dtb.2021.235528rep
El-Khatib L, Alrayes H, Sallam O, Elbanna A. Republished: Quinidine hypersensitivity: a side effect of a forgotten antiarrhythmic. Drug Ther Bull. 2021 May;59(5):77-79. doi: 10.1136/dtb.2021.235528rep. Epub 2021 Jan 28. PMID: 33509835.
Copy Download .nbib Format: NLM
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Clinical pharmacology and therapeutics

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.
PMID: 30079582
Clin Pharmacol Ther. 2019 Aug;106(2):374-382. doi: 10.1002/cpt.1194. Epub 2018 Sep 02.

Nonadherence to treatment is a major cause of lupus flares. Hydroxychloroquine (HCQ), a major medication in systemic lupus erythematosus, has a long half-life and can be quantified by high-performance liquid chromatography. This international study evaluated nonadherence in 305 lupus...

Cite
Costedoat-Chalumeau N, Houssiau F, Izmirly P, et al. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires. Clin Pharmacol Ther. 2018;106(2):374-382doi: 10.1002/cpt.1194.
Costedoat-Chalumeau, N., Houssiau, F., Izmirly, P., Guern, V. L., Navarra, S., Jolly, M., Ruiz-Irastorza, G., Baron, G., Hachulla, E., Agmon-Levin, N., Shoenfeld, Y., Dall'Ara, F., Buyon, J., Deligny, C., Cervera, R., Lazaro, E., Bezanahary, H., Leroux, G., Morel, N., Viallard, J. F., Pineau, C., Galicier, L., Vollenhoven, R. V., Tincani, A., Nguyen, H., Gondran, G., Zahr, N., Pouchot, J., Piette, J. C., Petri, M., & Isenberg, D. (2019). A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires. Clinical pharmacology and therapeutics, 106(2), 374-382. https://doi.org/10.1002/cpt.1194
Costedoat-Chalumeau, Nathalie, et al. "A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires." Clinical pharmacology and therapeutics vol. 106,2 (2019): 374-382. doi: https://doi.org/10.1002/cpt.1194
Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires. Clin Pharmacol Ther. 2019 Aug;106(2):374-382. doi: 10.1002/cpt.1194. Epub 2018 Sep 02. PMID: 30079582.
Copy Download .nbib Format: NLM
Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy.

JAMA

[No authors listed]
PMID: 32749489
JAMA. 2020 Aug 04;324(5):505. doi: 10.1001/jama.2020.0753.

No abstract available.

Cite
Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy. JAMA. 2020;324(5):505doi: 10.1001/jama.2020.0753.
(2020). Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy. JAMA, 324(5), 505. https://doi.org/10.1001/jama.2020.0753
"Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy." JAMA vol. 324,5 (2020): 505. doi: https://doi.org/10.1001/jama.2020.0753
Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy. JAMA. 2020 Aug 04;324(5):505. doi: 10.1001/jama.2020.0753. PMID: 32749489.
Copy Download .nbib Format: NLM
Analysing repeated hospital readmissions using data mining techniques.

Health systems (Basingstoke, England)

Ben-Assuli O, Padman R.
PMID: 31215903
Health Syst (Basingstoke). 2018 Nov 09;7(3):166-180. doi: 10.1080/20476965.2018.1510040. eCollection 2018.

Few studies have examined how to identify future readmission of patients with a large number of repeat emergency department (ED) visits. We explore 30-day readmission risk prediction using Microsoft's AZURE machine learning software and compare five classification methods: Logistic...

Cite
Ben-Assuli O, Padman R. Analysing repeated hospital readmissions using data mining techniques. Health Syst (Basingstoke). 2018;7(3):166-180doi: 10.1080/20476965.2018.1510040.
Ben-Assuli, O., & Padman, R. (2018). Analysing repeated hospital readmissions using data mining techniques. Health systems (Basingstoke, England), 7(3), 166-180. https://doi.org/10.1080/20476965.2018.1510040
Ben-Assuli, Ofir, and Padman, Rema. "Analysing repeated hospital readmissions using data mining techniques." Health systems (Basingstoke, England) vol. 7,3 (2018): 166-180. doi: https://doi.org/10.1080/20476965.2018.1510040
Ben-Assuli O, Padman R. Analysing repeated hospital readmissions using data mining techniques. Health Syst (Basingstoke). 2018 Nov 09;7(3):166-180. doi: 10.1080/20476965.2018.1510040. eCollection 2018. PMID: 31215903; PMCID: PMC6452835.
Copy Download .nbib Format: NLM
Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggest Dentate Gyrus Pathology Linked to NMDA Receptor Hypofunction.

Biological psychiatry. Cognitive neuroscience and neuroimaging

Kraguljac NV, Carle M, Frölich MA, Tran S, Yassa MA, White DM, Reddy A, Lahti AC.
PMID: 34649019
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Dec;6(12):1185-1192. doi: 10.1016/j.bpsc.2021.09.008. Epub 2021 Oct 12.

BACKGROUND: Converging evidence from neuroimaging and postmortem studies suggests that hippocampal subfields are differentially affected in schizophrenia. Recent studies report dentate gyrus dysfunction in chronic schizophrenia, but the underlying mechanisms remain to be elucidated. Here, we sought to examine...

Cite
Kraguljac NV, Carle M, Frölich MA, et al. Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggest Dentate Gyrus Pathology Linked to NMDA Receptor Hypofunction. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(12):1185-1192doi: 10.1016/j.bpsc.2021.09.008.
Kraguljac, N. V., Carle, M., Frölich, M. A., Tran, S., Yassa, M. A., White, D. M., Reddy, A., & Lahti, A. C. (2021). Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggest Dentate Gyrus Pathology Linked to NMDA Receptor Hypofunction. Biological psychiatry. Cognitive neuroscience and neuroimaging, 6(12), 1185-1192. https://doi.org/10.1016/j.bpsc.2021.09.008
Kraguljac, Nina Vanessa, et al. "Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggest Dentate Gyrus Pathology Linked to NMDA Receptor Hypofunction." Biological psychiatry. Cognitive neuroscience and neuroimaging vol. 6,12 (2021): 1185-1192. doi: https://doi.org/10.1016/j.bpsc.2021.09.008
Kraguljac NV, Carle M, Frölich MA, Tran S, Yassa MA, White DM, Reddy A, Lahti AC. Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggest Dentate Gyrus Pathology Linked to NMDA Receptor Hypofunction. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Dec;6(12):1185-1192. doi: 10.1016/j.bpsc.2021.09.008. Epub 2021 Oct 12. PMID: 34649019.
Copy Download .nbib Format: NLM
Influenza Vaccine for 2020-2021.

JAMA

[No authors listed]
PMID: 33006598
JAMA. 2020 Nov 03;324(17):1777-1778. doi: 10.1001/jama.2020.19507.

No abstract available.

Cite
Influenza Vaccine for 2020-2021. JAMA. 2020;324(17):1777-1778doi: 10.1001/jama.2020.19507.
(2020). Influenza Vaccine for 2020-2021. JAMA, 324(17), 1777-1778. https://doi.org/10.1001/jama.2020.19507
"Influenza Vaccine for 2020-2021." JAMA vol. 324,17 (2020): 1777-1778. doi: https://doi.org/10.1001/jama.2020.19507
Influenza Vaccine for 2020-2021. JAMA. 2020 Nov 03;324(17):1777-1778. doi: 10.1001/jama.2020.19507. PMID: 33006598.
Copy Download .nbib Format: NLM
Correction and Republication: Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic - United States, March-April 2021.

MMWR. Morbidity and mortality weekly report

[No authors listed]
PMID: 34855728
MMWR Morb Mortal Wkly Rep. 2021 Dec 03;70(48):1679. doi: 10.15585/mmwr.mm7048a5.

No abstract available.

Cite
Correction and Republication: Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic - United States, March-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(48):1679doi: 10.15585/mmwr.mm7048a5.
(2021). Correction and Republication: Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic - United States, March-April 2021. MMWR. Morbidity and mortality weekly report, 70(48), 1679. https://doi.org/10.15585/mmwr.mm7048a5
"Correction and Republication: Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic - United States, March-April 2021." MMWR. Morbidity and mortality weekly report vol. 70,48 (2021): 1679. doi: https://doi.org/10.15585/mmwr.mm7048a5
Correction and Republication: Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic - United States, March-April 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 03;70(48):1679. doi: 10.15585/mmwr.mm7048a5. PMID: 34855728.
Copy Download .nbib Format: NLM
Republished: An unusually impressive atorvastatin-induced elevation of serum alkaline phosphatase.

Drug and therapeutics bulletin

Chapman G, Tanner S.
PMID: 33093078
Drug Ther Bull. 2021 Mar;59(3):43-47. doi: 10.1136/dtb.2020.231839rep. Epub 2020 Oct 22.

No abstract available.

Cite
Chapman G, Tanner S. Republished: An unusually impressive atorvastatin-induced elevation of serum alkaline phosphatase. Drug Ther Bull. 2020;59(3):43-47doi: 10.1136/dtb.2020.231839rep.
Chapman, G., & Tanner, S. (2021). Republished: An unusually impressive atorvastatin-induced elevation of serum alkaline phosphatase. Drug and therapeutics bulletin, 59(3), 43-47. https://doi.org/10.1136/dtb.2020.231839rep
Chapman, George, and Tanner, Stephanie. "Republished: An unusually impressive atorvastatin-induced elevation of serum alkaline phosphatase." Drug and therapeutics bulletin vol. 59,3 (2021): 43-47. doi: https://doi.org/10.1136/dtb.2020.231839rep
Chapman G, Tanner S. Republished: An unusually impressive atorvastatin-induced elevation of serum alkaline phosphatase. Drug Ther Bull. 2021 Mar;59(3):43-47. doi: 10.1136/dtb.2020.231839rep. Epub 2020 Oct 22. PMID: 33093078.
Copy Download .nbib Format: NLM
Republished: Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia.

Drug and therapeutics bulletin

Isse N, Hashimoto M.
PMID: 33766923
Drug Ther Bull. 2021 Apr;59(4):60-63. doi: 10.1136/dtb.2021.235385rep.

No abstract available.

Cite
Isse N, Hashimoto M. Republished: Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia. Drug Ther Bull. 2021;59(4):60-63doi: 10.1136/dtb.2021.235385rep.
Isse, N., & Hashimoto, M. (2021). Republished: Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia. Drug and therapeutics bulletin, 59(4), 60-63. https://doi.org/10.1136/dtb.2021.235385rep
Isse, Naohi, and Hashimoto, Masashi. "Republished: Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia." Drug and therapeutics bulletin vol. 59,4 (2021): 60-63. doi: https://doi.org/10.1136/dtb.2021.235385rep
Isse N, Hashimoto M. Republished: Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia. Drug Ther Bull. 2021 Apr;59(4):60-63. doi: 10.1136/dtb.2021.235385rep. PMID: 33766923.
Copy Download .nbib Format: NLM
Showing 157 to 165 of 165 entries